Natera

About:

Natera specializes in cell-free DNA testing to provide a more targeted interventions to oncology, women's health, and organ health.

Website: https://www.natera.com/

Twitter/X: NateraGenetics

Top Investors: OrbiMed, RA Capital Management, Sequoia Capital, Lightspeed Venture Partners, Founders Fund

Description:

Natera specializes in cell-free DNA testing and is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. Surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing.

Total Funding Amount:

$1.16B

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

San Carlos, California, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)natera.com

Founders:

Jonathan Sheena, Matthew Rabinowitz

Number of Employees:

1001-5000

Last Funding Date:

2023-09-07

IPO Status:

Public

© 2025 bioDAO.ai